These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Similar susceptibility to halothane, caffeine and ryanodine in vitro reflects pharmacogenetic variability of malignant hyperthermia. Ginz HF, Girard T, Censier K, Urwyler A. Eur J Anaesthesiol; 2004 Feb; 21(2):151-7. PubMed ID: 14977348 [Abstract] [Full Text] [Related]
25. [Caffeine skinned fiber tension test: application to the diagnosis of susceptibility to malignant hyperthermia]. Adnet P, Börtlein ML, Tavernier B, Nivoche Y, Etchrivi T, Krivosic-Horber R, Haudecoeur G. Ann Fr Anesth Reanim; 1999 Jun; 18(6):624-30. PubMed ID: 10464528 [Abstract] [Full Text] [Related]
26. C1840-T mutation in the human skeletal muscle ryanodine receptor gene: frequency in northern German families susceptible to malignant hyperthermia and the relationship to in vitro contracture response. Steinfath M, Singh S, Scholz J, Becker K, Lenzen C, Wappler F, Köchling A, Roewer N, Schulte am Esch J. J Mol Med (Berl); 1995 Jan; 73(1):35-40. PubMed ID: 7633940 [Abstract] [Full Text] [Related]
27. Is there a link between exertional heat stroke and susceptibility to malignant hyperthermia? Sagui E, Montigon C, Abriat A, Jouvion A, Duron-Martinaud S, Canini F, Zagnoli F, Bendahan D, Figarella-Branger D, Brégigeon M, Brosset C. PLoS One; 2015 Jan; 10(8):e0135496. PubMed ID: 26258863 [Abstract] [Full Text] [Related]
33. Results of contracture tests with halothane, caffeine, and ryanodine depend on different malignant hyperthermia-associated ryanodine receptor gene mutations. Fiege M, Wappler F, Weisshorn R, Ulrich Gerbershagen M, Steinfath M, Schulte Am Esch J. Anesthesiology; 2002 Aug; 97(2):345-50. PubMed ID: 12151923 [Abstract] [Full Text] [Related]
34. Effects of caffeine, halothane, and 4-chloro-m-cresol on skeletal muscle lactate and pyruvate in malignant hyperthermia-susceptible and normal swine as assessed by microdialysis. Bina S, Cowan G, Karaian J, Muldoon S, Mongan P, Bünger R. Anesthesiology; 2006 Jan; 104(1):90-100. PubMed ID: 16394695 [Abstract] [Full Text] [Related]
35. [Application of caffeine-halothane contracture test in the diagnosis of malignant hyperthermia]. Wang YL, Guo XY, Xu ZH, Huang YG, Luo AL. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Apr; 30(2):182-6. PubMed ID: 18505122 [Abstract] [Full Text] [Related]
36. Multicentre evaluation of in vitro contracture testing with bolus administration of 4-chloro-m-cresol for diagnosis of malignant hyperthermia susceptibility. Wappler F, Anetseder M, Baur CP, Censier K, Doetsch S, Felleiter P, Fiege M, Fricker R, Halsall PJ, Hartung E, Heffron JJ, Heytens L, Hopkins PM, Klingler W, Lehmann-Horn F, Nivoche Y, Tegazzin V, Tzanova I, Urwyler A, Weisshorn R, Schulte am Esch J. Eur J Anaesthesiol; 2003 Jul; 20(7):528-36. PubMed ID: 12884985 [Abstract] [Full Text] [Related]
37. ATX II, a sodium channel toxin, sensitizes skeletal muscle to halothane, caffeine, and ryanodine. Fletcher JE, Adnet PJ, Reyford H, Wieland SJ, Stewart SL, Rosenberg H. Anesthesiology; 1999 May; 90(5):1294-301. PubMed ID: 10319776 [Abstract] [Full Text] [Related]
38. Effect of cocaine on the contracture response to 1% halothane in patients undergoing diagnostic muscle biopsy for malignant hyperthermia. Sato N, Brum JM, Mitsumoto H, DeBoer GE. Can J Anaesth; 1995 Feb; 42(2):158-62. PubMed ID: 7720160 [Abstract] [Full Text] [Related]
39. Sevoflurane is less sensitive than halothane for in vitro detection of malignant hyperthermia susceptibility. Johannsen S, Klingler W, Schneiderbanger D, Heiderich S, Roewer N, Schuster F. Acta Anaesthesiol Scand; 2013 Oct; 57(9):1161-6. PubMed ID: 23957432 [Abstract] [Full Text] [Related]
40. Abnormal calcium signalling and the caffeine-halothane contracture test. Figueroa L, Kraeva N, Manno C, Toro S, Ríos E, Riazi S. Br J Anaesth; 2019 Jan; 122(1):32-41. PubMed ID: 30579404 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]